B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 198.4 DKK 3.09% Market Closed
Market Cap: 15.6B DKK
Have any thoughts about
Bavarian Nordic A/S?
Write Note

Intrinsic Value

The intrinsic value of one BAVA stock under the Base Case scenario is 168.42 DKK. Compared to the current market price of 198.4 DKK, Bavarian Nordic A/S is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BAVA Intrinsic Value
168.42 DKK
Overvaluation 15%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bavarian Nordic A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BAVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BAVA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bavarian Nordic A/S

Provide an overview of the primary business activities
of Bavarian Nordic A/S.

What unique competitive advantages
does Bavarian Nordic A/S hold over its rivals?

What risks and challenges
does Bavarian Nordic A/S face in the near future?

Summarize the latest earnings call
of Bavarian Nordic A/S.

What significant events have occurred
in Bavarian Nordic A/S over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bavarian Nordic A/S.

Provide P/S
for Bavarian Nordic A/S.

Provide P/E
for Bavarian Nordic A/S.

Provide P/OCF
for Bavarian Nordic A/S.

Provide P/FCFE
for Bavarian Nordic A/S.

Provide P/B
for Bavarian Nordic A/S.

Provide EV/S
for Bavarian Nordic A/S.

Provide EV/GP
for Bavarian Nordic A/S.

Provide EV/EBITDA
for Bavarian Nordic A/S.

Provide EV/EBIT
for Bavarian Nordic A/S.

Provide EV/OCF
for Bavarian Nordic A/S.

Provide EV/FCFF
for Bavarian Nordic A/S.

Provide EV/IC
for Bavarian Nordic A/S.

Show me price targets
for Bavarian Nordic A/S made by professional analysts.

What are the Revenue projections
for Bavarian Nordic A/S?

How accurate were the past Revenue estimates
for Bavarian Nordic A/S?

What are the Net Income projections
for Bavarian Nordic A/S?

How accurate were the past Net Income estimates
for Bavarian Nordic A/S?

What are the EPS projections
for Bavarian Nordic A/S?

How accurate were the past EPS estimates
for Bavarian Nordic A/S?

What are the EBIT projections
for Bavarian Nordic A/S?

How accurate were the past EBIT estimates
for Bavarian Nordic A/S?

Compare the revenue forecasts
for Bavarian Nordic A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bavarian Nordic A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bavarian Nordic A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bavarian Nordic A/S compared to its peers.

Compare the P/E ratios
of Bavarian Nordic A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Bavarian Nordic A/S with its peers.

Analyze the financial leverage
of Bavarian Nordic A/S compared to its main competitors.

Show all profitability ratios
for Bavarian Nordic A/S.

Provide ROE
for Bavarian Nordic A/S.

Provide ROA
for Bavarian Nordic A/S.

Provide ROIC
for Bavarian Nordic A/S.

Provide ROCE
for Bavarian Nordic A/S.

Provide Gross Margin
for Bavarian Nordic A/S.

Provide Operating Margin
for Bavarian Nordic A/S.

Provide Net Margin
for Bavarian Nordic A/S.

Provide FCF Margin
for Bavarian Nordic A/S.

Show all solvency ratios
for Bavarian Nordic A/S.

Provide D/E Ratio
for Bavarian Nordic A/S.

Provide D/A Ratio
for Bavarian Nordic A/S.

Provide Interest Coverage Ratio
for Bavarian Nordic A/S.

Provide Altman Z-Score Ratio
for Bavarian Nordic A/S.

Provide Quick Ratio
for Bavarian Nordic A/S.

Provide Current Ratio
for Bavarian Nordic A/S.

Provide Cash Ratio
for Bavarian Nordic A/S.

What is the historical Revenue growth
over the last 5 years for Bavarian Nordic A/S?

What is the historical Net Income growth
over the last 5 years for Bavarian Nordic A/S?

What is the current Free Cash Flow
of Bavarian Nordic A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bavarian Nordic A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bavarian Nordic A/S

Current Assets 5.4B
Cash & Short-Term Investments 2.2B
Receivables 1.1B
Other Current Assets 2.1B
Non-Current Assets 8.9B
PP&E 2.4B
Intangibles 6.5B
Other Non-Current Assets 22.8m
Current Liabilities 3.6B
Accounts Payable 1.1B
Accrued Liabilities 442.7m
Other Current Liabilities 2.1B
Non-Current Liabilities 188.3m
Long-Term Debt 82.7m
Other Non-Current Liabilities 105.6m
Efficiency

Earnings Waterfall
Bavarian Nordic A/S

Revenue
6.1B DKK
Cost of Revenue
-2.6B DKK
Gross Profit
3.5B DKK
Operating Expenses
-2.7B DKK
Operating Income
723.6m DKK
Other Expenses
-16.2m DKK
Net Income
707.4m DKK

Free Cash Flow Analysis
Bavarian Nordic A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BAVA Profitability Score
Profitability Due Diligence

Bavarian Nordic A/S's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
ROIC is Increasing
45/100
Profitability
Score

Bavarian Nordic A/S's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

BAVA Solvency Score
Solvency Due Diligence

Bavarian Nordic A/S's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
87/100
Solvency
Score

Bavarian Nordic A/S's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BAVA Price Targets Summary
Bavarian Nordic A/S

Wall Street analysts forecast BAVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BAVA is 317.9 DKK with a low forecast of 247.45 DKK and a high forecast of 393.75 DKK.

Lowest
Price Target
247.45 DKK
25% Upside
Average
Price Target
317.9 DKK
60% Upside
Highest
Price Target
393.75 DKK
98% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BAVA?

Click here to dive deeper.

Dividends

Bavarian Nordic A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for BAVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

BAVA News

Other Videos

Profile

Bavarian Nordic A/S

Country

Denmark

Industry

Biotechnology

Market Cap

15.5B DKK

Dividend Yield

0%

Description

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The firm is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

Contact

Hellerup
Philip Heymans Alle 3
+4533268383.0
www.bavarian-nordic.com

IPO

1998-11-02

Employees

750

Officers

CEO & President
Dr. Paul John Chaplin MSc, Ph.D.
CFO & Executive VP
Mr. Henrik Juuel M.Sc.
Executive VP & COO
Mr. Russell Thirsk M.Sc.
Vice President of Investor Relations & Communications
Mr. Rolf Sass Sørensen
Executive VP and Chief People & Sustainability Officer
Ms. Anu Helena Kerns M.Sc.
Executive VP & Chief Commercial Officer
Mr. Jean-Christophe May M.B.A., Pharm.D.

See Also

Discover More
What is the Intrinsic Value of one BAVA stock?

The intrinsic value of one BAVA stock under the Base Case scenario is 168.42 DKK.

Is BAVA stock undervalued or overvalued?

Compared to the current market price of 198.4 DKK, Bavarian Nordic A/S is Overvalued by 15%.

Back to Top